Health Highlights: March 28, 2022
Ernie Mundell
Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more
Second COVID-19 vaccine boosters to be offered to Americans over 50. Optional second boosters of the Pfizer or Moderna vaccines could be authorized by the U.S. Food and Drug Administration as early as this week. But debate rages over the timing and effectiveness of such a move. Read more
Owners can play big role in dogs' problem behaviors. Nearly 1 in 3 pet dogs suffer from ADHD-like repetitive behaviors, and researchers now suspect that an animal's home life could be the cause. Read more
Hospitalization extremely rare for the vaccinated or those with prior COVID infection. A study of more than 100,000 American patients found their odds of winding up in the hospital following a 'breakthrough' infection was practically nil. Read more
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.